Cargando…
Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms
Autores principales: | Raucci, Federica, Mansour, Adel Abo, Casillo, Gian Marco, Saviano, Anella, Caso, Francesco, Scarpa, Raffaele, Mascolo, Nicola, Iqbal, Asif Jilani, Maione, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252120/ https://www.ncbi.nlm.nih.gov/pubmed/32376393 http://dx.doi.org/10.1016/j.autrev.2020.102572 |
Ejemplares similares
-
Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome?
por: Casillo, Gian Marco, et al.
Publicado: (2020) -
Galectin-9 Regulates Monosodium Urate Crystal-Induced Gouty Inflammation Through the Modulation of Treg/Th17 Ratio
por: Mansour, Adel Abo, et al.
Publicado: (2021) -
In-depth immunophenotyping data relating to IL-17Ab modulation of circulating Treg/Th17 cells and of in situ infiltrated inflammatory monocytes in the onset of gouty inflammation
por: Raucci, Federica, et al.
Publicado: (2019) -
Present Status and Future Trends of Natural-Derived Compounds Targeting T Helper (Th) 17 and Microsomal Prostaglandin E Synthase-1 (mPGES-1) as Alternative Therapies for Autoimmune and Inflammatory-Based Diseases
por: Saviano, Anella, et al.
Publicado: (2020) -
Interleukin-17A (IL-17A): A silent amplifier of COVID-19
por: Maione, Francesco, et al.
Publicado: (2021)